Clinical Trials · NCT00099320
Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- AstraZeneca
- Enrollment
- 182
- Start date
- May 2004
- Locations
- 51 sites, 3 countries
- Primary endpoint
- Change in HbA1c (glycosylated hemoglobin) from Baseline to Week 16, and if measured, any visits in between